Cargando…
Comparing mutation calls in fixed tumour samples between the affymetrix OncoScan® array and PCR based next-generation sequencing
BACKGROUND: The importance of accurate and affordable mutation calling in fixed pathology samples is becoming increasingly important as we move into the era of personalised medicine. The Affymetrix OncoScan® Array platform is designed to produce actionable mutation calls in archival material. METHOD...
Autores principales: | Wood, Henry M., Foster, Joseph M., Taylor, Morag, Tinkler-Hundal, Emma, Togneri, Fiona S., Wojtowicz, Paula, Oumie, Assa, Spink, Karen G., Brew, Fiona, Quirke, Philip |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5357332/ https://www.ncbi.nlm.nih.gov/pubmed/28315634 http://dx.doi.org/10.1186/s12920-017-0254-5 |
Ejemplares similares
-
Cross-laboratory validation of the OncoScan® FFPE Assay, a multiplex tool for whole genome tumour profiling
por: Foster, Joseph M, et al.
Publicado: (2015) -
Detection of cytogenomic abnormalities by OncoScan microarray assay for products of conception from formalin-fixed paraffin-embedded and fresh fetal tissues
por: Wen, Jiadi, et al.
Publicado: (2021) -
Prediction of early-stage hepatocellular carcinoma using OncoScan chromosomal copy number aberration data
por: Yu, Ming-Chin, et al.
Publicado: (2017) -
Spatial normalization improves the quality of genotype calling for Affymetrix SNP 6.0 arrays
por: Chai, High Seng, et al.
Publicado: (2010) -
Genotyping and annotation of Affymetrix SNP arrays
por: Lamy, Philippe, et al.
Publicado: (2006)